David Israeli

6PUBLICATIONS
18CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyMedical mycologyMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 14, 2026
Muscle meets Lysosomes: emerging strategies in muscular dystrophy.

Abbass Jaber, David Israeli

|Oct 22, 2025
Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy.

Abbass Jaber, Laura Palmieri, Rania Bakour

|Oct 20, 2022
Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy.

Ai Vu Hong, Nathalie Bourg, Peggy Sanatine

|Feb 26, 2022
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy.

Nathalie Bourg, Ai Vu Hong, William Lostal

|May 26, 2021
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy.

Fatima Amor, Ai Vu Hong, Guillaume Corre

Pageof 1